{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:38:16Z","timestamp":1792525096120,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health and Aged Care, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Pharmacy Diabetes Screening Trial (PDST) evaluated three approaches to screening for undiagnosed type 2 diabetes mellitus (T2DM) in community pharmacy: (1) paper-based risk assessment (AUSDRISK) alone; and AUSDRISK followed by a point of care test if AUSDRISK\u2009\u2265\u200912; with either (2) HbA1c; or (3) small capillary blood glucose Test (scBGT). This paper reports the perspectives and experiences of the pharmacy screening service of two key stakeholder groups: screening participants and general practitioners (GPs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All referred participants (<jats:italic>n<\/jats:italic>\u2009=\u20092242) received an online survey to determine the outcome of the referral, as well as their level of satisfaction with the service. In addition, a random sample of 2,989 (20%) of non-referred participants were surveyed to determine their overall experience and level of satisfaction with the service. GPs to whom participants were referred were contacted to establish if, since the date of the screening service, their patient had (1) been to see them; (2) had further tests performed (FBG, RBG, OGTT, HbA1c); or (3) been diagnosed with diabetes or prediabetes. Descriptive statistics were reported for quantitative data. Factors associated with visiting the GP following screening were assessed using multivariable logistic regression. Qualitative data were analysed using content analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Response rates 16% (<jats:italic>n<\/jats:italic>\u2009=\u2009369) and 17% (<jats:italic>n<\/jats:italic>\u2009=\u2009520) were achieved for the three-month referred and non-referred participant surveys, respectively. Over 90% of respondents were very positive about the screening service (<jats:italic>n<\/jats:italic>\u2009=\u2009784\/853) and would recommend it to a family member or friend (<jats:italic>n<\/jats:italic>\u2009=\u2009784\/853). Participants also reported making significant improvements in diet and exercise, because of the screening. Among referred respondents, those who received a POC test were twice as likely to visit their GP compared to those who received a risk assessment only (OR 2.11 95% CI 1.46\u20133.06<jats:bold>)<\/jats:bold>. GPs (15.8% response rate, <jats:italic>n<\/jats:italic>\u2009=\u200957\/361) indicated that the referral worked well and that recommendations for follow-up care by the pharmacist were appropriate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Opportunistic screening of individuals during routine encounters with the community pharmacy in a previously undiagnosed population has been shown to foster positive engagement with consumers and GPs, which may assist in reducing the burden of T2DM on the individual and the community.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-10269-1","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T14:02:29Z","timestamp":1701439349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Ines","family":"Krass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Twigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peta","family":"Trinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophy T. F.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent L.","family":"Versace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"10269_CR1","unstructured":"Diabetes Australia. Diabetes in Australia. Diabetes in Australia.\u00a0https:\/\/www.diabetesaustralia.com.au\/about-diabetes\/diabetes-in-australia\/ Accessed 3 Feb 2023."},{"key":"10269_CR2","unstructured":"International Diabetes Federation: Diabetes Report 2000 \u2014 2045, Australia. In The IDF Diabetes Atlas 2021 10th edition. https:\/\/diabetesatlas.org\/data\/en\/country\/11\/au.html. Accessed 3 Feb s2023."},{"key":"10269_CR3","unstructured":"Baker IDI Heart and Diabetes Institute: Diabetes: the silent pandemic and its impact on Australia. In. Melbourne, Australia: Baker IDI in partnership Diabetes Australia and the Juvenile Diabetes Research Foundation; 2012. https:\/\/baker.edu.au\/-\/media\/documents\/impact\/diabetes-the-silent-pandemic.pdf?la=en. Accessed 3 Feb 2023."},{"key":"10269_CR4","unstructured":"The Royal Australian College of General Practitioners: General practice management of type 2 diabetes 2020. https:\/\/www.racgp.org.au\/getattachment\/41fee8dc-7f97-4f87-9d90-b7af337af778\/Management-of-type-2-diabetes-A-handbook-for-general-practice.aspx. Accessed 3 Feb 2023."},{"key":"10269_CR5","volume-title":"Recommendations For Managing Type 2 Diabetes In Primary Care","author":"International Diabetes Federation","year":"2017","unstructured":"International Diabetes Federation. Recommendations For Managing Type 2 Diabetes In Primary Care. 2017. https:\/\/www.idf.org\/managing-type2-diabetes.\u00a0\u00a0Accessed 3 Feb s2023."},{"key":"10269_CR6","unstructured":"Australian Institute of Health and Welfare 2020. Coordination of health care: experiences of barriers to accessing health services among patients aged 45 and over 2016. Cat. no. CHC 4. Canberra: AIHW. https:\/\/www.aihw.gov.au\/getmedia\/d864d80b-22cb-4356-a1f6-24c2f350004b\/aihw-chc-4.pdf.aspx?inline=true. Accessed 3 Feb s2023."},{"key":"10269_CR7","unstructured":"Swerissen H, Duckett S, Moran G. Mapping primary care in Australia. Grattan Institute; 2018. https:\/\/grattan.edu.au\/report\/mapping-primary-care-in-australia\/. Accessed 3 Feb 2023."},{"key":"10269_CR8","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/ndt\/gfr599","volume":"27","author":"M Razavian","year":"2012","unstructured":"Razavian M, Heeley EL, Perkovic V, Zoungas S, Weekes A, Patel AA, et al. Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Nephrol Dial Transplant. 2012;27:1396\u2013402.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10269_CR9","doi-asserted-by":"publisher","first-page":"e007093","DOI":"10.1161\/JAHA.117.007093","volume":"6","author":"D Peiris","year":"2017","unstructured":"Peiris D, Usherwood T, Li Q, Harris MF, Panaretto K, Zwar N, et al. Impact of Sustained use of a multifaceted computerized quality improvement intervention for cardiovascular disease management in australian primary health care. J Am Heart Assocs. 2017;6(10):e007093.","journal-title":"J Am Heart Assocs"},{"key":"10269_CR10","unstructured":"Morgan, M., Peters, D., Hopwood, M., Castle, D., Moy, C., Fehily, C. et al.\u00a0Being equally well: Better physical health care and longer lives for people living with serious mental illness. Technical Report 2021.03. Mitchell Institute, Victoria University.\u00a0https:\/\/www.vu.edu.au\/sites\/default\/files\/being-equally-well-policy-roadmap-mitchell-institute.pdf. Accessed 3 Feb 2023."},{"key":"10269_CR11","unstructured":"World Health Organization. Joint FIP\/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services In., vol. WHO Technical Report Series No 961: World Health Organization; 2011. https:\/\/www.who.int\/docs\/default-source\/medicines\/norms-and-standards\/guidelines\/distribution\/trs961-annex8-fipwhoguidelinesgoodpharmacypractice.pdf. Accessed 3 Feb s2023."},{"key":"10269_CR12","unstructured":"The Pharmacy Guild of Australia. Vital Facts on Community Phamacy 2018. https:\/\/www.guild.org.au\/__data\/assets\/pdf_file\/0020\/12908\/Vital-facts-on-community-pharmacy.pdf. Accessed 3 Feb 2023."},{"issue":"4","key":"10269_CR13","doi-asserted-by":"publisher","first-page":"e91157","DOI":"10.1371\/journal.pone.0091157","volume":"9","author":"A Willis","year":"2014","unstructured":"Willis A, Rivers P, Gray LJ, Davies M, Khunti K. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS One. 2014;9(4):e91157.","journal-title":"PLoS One"},{"key":"10269_CR14","unstructured":"Australian Government Department of Health. Australian National Diabetes Strategy 2021\u20132030. Commonwealth of Australia, Canberra. 2021. Online ISBN: 978\u20131\u201376007\u2013218\u20136. https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2021\/11\/australian-national-diabetes-strategy-2021-2030_0.pdf. Accessed 3 Feb 2023."},{"key":"10269_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5694\/j.1326-5377.2010.tb03478.x","volume":"192","author":"L Chen","year":"2010","unstructured":"Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, et al. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust. 2010;192:197\u2013202.","journal-title":"Med J Aust"},{"issue":"12","key":"10269_CR16","doi-asserted-by":"publisher","first-page":"e01s7725","DOI":"10.1136\/bmjopen-2017-017725","volume":"7","author":"I Krass","year":"2017","unstructured":"Krass I, Carter R, Mitchell B, Mohebbi M, Shih STF, Trinder P, et al. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. BMJ Open. 2017;7(12):e01s7725.","journal-title":"BMJ Open"},{"issue":"110566","key":"10269_CR17","doi-asserted-by":"publisher","first-page":"0168","DOI":"10.1016\/j.diabres.2023.110566","volume":"197","author":"I Krass","year":"2023","unstructured":"Krass I, Carter R, Mitchell B, Mohebbi M, Shih STF, Trinder P, et al. Pharmacy Diabetes Screening Trial (PDST): outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy. Diab Res Clin Pract. 2023;197(110566):0168\u20138227. https:\/\/doi.org\/10.1016\/j.diabres.2023.110566.","journal-title":"Diab Res Clin Pract"},{"issue":"2","key":"10269_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"9","key":"10269_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388.","journal-title":"Qual Health Res"},{"issue":"9","key":"10269_CR20","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.sapharm.2020.12.013","volume":"17","author":"AHY Siu","year":"2021","unstructured":"Siu AHY, Krass I, Mitchell B, McNamara K. Implementation of diabetes screening in community pharmacy - factors influencing successful implementation. Res Social Adm Pharm. 2021;17(9):1606\u201313. https:\/\/doi.org\/10.1016\/j.sapharm.2020.12.013. Epub 2020 Dec 29 PMID: 33414090.","journal-title":"Res Social Adm Pharm"},{"key":"10269_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/ijpp.12301","volume":"25","author":"BV Bajorek","year":"2017","unstructured":"Bajorek BV, LeMay KS, Magin PJ, Roberts C, Krass I. Armour CL Management of hypertension in an Australian community pharmacy setting - patients\u2019 beliefs and perspectives. Int J Pharm Pract. 2017;25:263\u201373. https:\/\/doi.org\/10.1111\/ijpp.12301.","journal-title":"Int J Pharm Pract"},{"key":"10269_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.sapharm.2019.04.011","volume":"16","author":"KP Mc Namara","year":"2020","unstructured":"Mc Namara KP, Krass I, Peterson GM, Alzubaidi H, Grenfell R, Freedman B, et al. Implementing screening interventions in community pharmacy to promote interprofessional coordination of primary care - A mixed methods evaluation. Res Soc Admin Pharm. 2020;16:160\u20137.","journal-title":"Res Soc Admin Pharm"},{"key":"10269_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.diabres.2006.06.022","volume":"75","author":"I Krass","year":"2007","unstructured":"Krass I, Mitchell B, Clarke P, Brillant M, Dienaar R, Hughes J, et al. Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract. 2007;75:339\u201347.","journal-title":"Diabetes Res Clin Pract"},{"key":"10269_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/hex.12639","volume":"21","author":"AMK Hindi","year":"2018","unstructured":"Hindi AMK, Schafheutle EI, Jacobs S. Patient and public perspectives of community pharmacies in the United Kingdom: a systematic review. Health Expects. 2018;21:409\u201328.","journal-title":"Health Expects"},{"issue":"1","key":"10269_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12875-021-01421-z","volume":"22","author":"I Treciokiene","year":"2021","unstructured":"Treciokiene I, Postma M, Nguyen T, Fens T, Petkevicius J, Kubilius R, et al. Healthcare professional-led interventions on lifestyle modifications for hypertensive patients - a systematic review and meta-analysis. BMC Fam Pract. 2021;22(1):63. https:\/\/doi.org\/10.1186\/s12875-021-01421-z. PMID:33820547;PMCID:PMC8022420.","journal-title":"BMC Fam Pract"},{"issue":"3","key":"10269_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/pharmacy7030082","volume":"7","author":"A Peletidi","year":"2019","unstructured":"Peletidi A, Kayyali R. Experiences of the pharmacy-led weight management service: views of service providers in England. Pharmacy. 2019;7(3):82.","journal-title":"Pharmacy"},{"key":"10269_CR27","doi-asserted-by":"publisher","first-page":"e009s828","DOI":"10.1136\/bmjopen-2015-009828","volume":"6","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Todd A, O\u2019Malley C, Moore JM, Husband KH, Bambra C, et al. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open. 2016;6:e009s828. https:\/\/doi.org\/10.1136\/bmjopen-2015-009828.","journal-title":"BMJ Open"},{"key":"10269_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11096-012-9617-3","volume":"34","author":"E Hatah","year":"2012","unstructured":"Hatah E, Braund R, Duffull S, Tordoff J. General practitioners\u2019 perceptions of pharmacists\u2019 new services in New Zealand. Int J Clin Pharm. 2012;34:364\u201373.","journal-title":"Int J Clin Pharm"},{"key":"10269_CR29","unstructured":"Australian Government, Australian Digital Health Agency. MyHealth Record. https:\/\/www.myhealthrecord.gov.au\/. Accessed 3 Feb 2023."},{"issue":"6","key":"10269_CR30","doi-asserted-by":"publisher","first-page":"e13199","DOI":"10.2196\/13199","volume":"7","author":"O Byambasuren","year":"2019","unstructured":"Byambasuren O, Beller E, Glasziou P. Current knowledge and adoption of mobile health apps among Australian general practitioners: survey study. JMIR Mhealth Uhealth. 2019;7(6):e13199. https:\/\/doi.org\/10.2196\/13199. PMID:31199343PMCID:6592476.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"21","key":"10269_CR31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1071\/PY13129","volume":"2015","author":"Parkinson Anne","year":"2015","unstructured":"Anne Parkinson, Louisa Jorm, Douglas Kirsty A, Alison Gee, Sargent Ginny M, Sanja Lujic, McRae Ian S. Recruiting general practitioners for surveys: reflections on the difficulties and some lessons learned. Aust J Primary Health. 2015;2015(21):254\u20138 https:\/\/www.publish.csiro.au\/py\/ExportCitation\/PY13129.","journal-title":"Aust J Primary Health"},{"key":"10269_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12874-017-0353-1","volume":"17","author":"S Yu","year":"2017","unstructured":"Yu S, Alper HE, Nguyen AM, et al. The effectiveness of a monetary incentive offer on survey response rates and response completeness in a longitudinal study. BMC Med Res Methodol. 2017;17:77. https:\/\/doi.org\/10.1186\/s12874-017-0353-1.","journal-title":"BMC Med Res Methodol"},{"key":"10269_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2288-12-52)","volume":"12","author":"F Olsen","year":"2012","unstructured":"Olsen F, Abelsen B, Olsen JA. Improving response rate and quality of survey data with a scratch lottery ticket incentive. BMC Med Res Methodol. 2012;12:52. https:\/\/doi.org\/10.1186\/1471-2288-12-52).","journal-title":"BMC Med Res Methodol"},{"key":"10269_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0019-8501(02)00277-8","volume":"32","author":"PD Larson","year":"2001","unstructured":"Larson PD, Chow G. Total cost\/response rate trade-offs in mail survey research: impact of follow-up mailings and monetary incentives. Ind Mark Manags. 2001;32:533\u20137.","journal-title":"Ind Mark Manags"},{"issue":"5","key":"10269_CR35","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/ajr.12805","volume":"29","author":"VL Versace","year":"2021","unstructured":"Versace VL, Skinner TC, Bourke L, Harvey P, Barnett T. National analysis of the Modified Monash Model, population distribution and a socio-economic index to inform rural health workforce planning. Aust J Rural Health. 2021;29(5):801\u201310. https:\/\/doi.org\/10.1111\/ajr.12805. PMID:34672057.29.","journal-title":"Aust J Rural Health"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10269-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-10269-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10269-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T14:05:13Z","timestamp":1701439513000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-10269-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["10269"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-10269-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approvals for the consumer and GP studies\u00a0were obtained from the Human Research Ethics Committees at the University of Sydney and at Deakin University. All consumer and GP participants received an approved Participant Information Sheet (PIS) describing the studies and provided written informed consent to participate.The original Pharmacy Diabetes Screening Trial was registered as a clinical trial with the Australian New Zealand Clinical Trials Registry ACTRN12616001240437 (06\/09\/2016). This paper reports a secondary study associated with the trial. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1337"}}